Rhizen drug secures approval in the USA The United States Food and Drug Administration has granted accelerated approval for the drug Umbralisib.…martin02.10.2021
Novaremed secures US$50 million Basel biotech Novaremed is receiving US$50 million through an agreement with an investment group. Novaremed…martin02.03.2021
Axtria driving growth from Basel The US firm Axtria has established a new office in Basel. The company offers services…martin02.01.2021
Technologiepark Basel celebrates its role as a driver of innovation The Technologiepark Basel will be ten years old in 2021. Over the past decade, it…martin01.28.2021
Basel Area has ever more to offer investors The canton of Basel-Stadt has displayed the most striking performance in the Swiss Venture Capital…martin01.28.2021
Basel researchers developing universal cancer therapy Researchers from Basel are working on the development of a therapy in which pre-prepared immune…martin01.26.2021
Opterion Health AG moving to Muttenz Opterion is moving from the canton of Obwalden to Muttenz in the canton of Basel-Landschaft…martin01.22.2021
Evolva brings natural sugar blocker to market The biotech company Evolva is introducing L-arabinose to the market. This product is a natural…martin01.21.2021
Holmusk opens new office in Basel Holmusk has opened an office in Basel. The company from Singapore develops digital therapies on…martin01.18.2021
Zifo RnD Solutions coming to Basel Zifo RnD Solutions, a global provider of IT solutions for research-based organizations, opens its latest…martin01.04.2021